Focus Pharmaceuticals

Focus Pharmaceuticals is a UK-based specialty pharmaceutical company that specializes in the acquisition, development, and commercialization of niche generic and branded prescription medicines. The company's portfolio spans multiple therapeutic areas, including dermatology, endocrinology, and gastroenterology, with a focus on providing cost-effective solutions to the National Health Service (NHS). In 2014, Focus was acquired by AMCo (now Advanz Pharma), significantly expanding the parent company's product range and market presence in the UK. The company operates by identifying off-patent or underserved medical needs and ensuring a reliable supply of high-quality pharmaceuticals.